Video

Krista Qualmann on the Effect of Genetic Testing on Treatment in Brain Cancer

Krista Qualmann, MS, CGC, genetic counselor at the Memorial Hermann Mischer Neuroscience Institute at the Texas Medical Center and UTHealth, discusses the implications that genetic testing results can have on treatment options for patients with brain cancer.

For some hereditary syndromes, certain treatments might be more or less effective. As an example, patients with low-grade gliomas and certain syndromes should avoid ionizing radiation, Qualmann says. Additionally, testing is important to keep in mind when considering screening for other cancers. Many syndromes, including Li-Fraumeni syndrome, can put a patient at higher risk for other cancer types.

<<<

View more from the 2016 SNO Annual Meeting

Related Videos
J. Bradley Elder, MD
Rimas V. Lukas, MD
Cedric Pobel, MD
Paolo Caimi, MD
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Haley M. Hill, PA-C, discusses the role of multidisciplinary management in NRG1-positive non–small cell lung cancer and pancreatic cancer.